Key facts
- This page summarizes Thomas M. Krummel's Form 4 filing for PROCEPT BioRobotics Corp (PRCT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Jun 2024, 16:28.
Thomas M. Krummel - 04 Jun 2024 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)
- Reporting relationship
- Director
- Issuer ticker
- PRCT
- Reported as of
- 04 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Jun 2024, 16:28:39 UTC
- Prior SEC filing
- 15 May 2024
- Next SEC filing
- 06 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jonathan Stone, Attorney -in-Fact for Thomas M. Krummel
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas M. Krummel filed Form 4 for PROCEPT BioRobotics Corp (PRCT) on 06 Jun 2024.
Change
- Previous filing in this sequence was filed on 15 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PRCT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,376
- Change %
- +3%
- Price
- $0.000000
- Shares after
- 47,007
- Date
- 04 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PRCT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +2,526
- Change %
- Price
- $0.000000
- Shares after
- 2,526
- Date
- 04 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,526
- Exercise price
- $67.29
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
Footnote F2
The Stock Option was granted on June 4, 2024 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.